These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 24218270)

  • 1. Quantification of complement receptor 2 calcium signaling enhancement using flow cytometry.
    Donius LR; Weis JH
    Methods Mol Biol; 2014; 1100():311-7. PubMed ID: 24218270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of complement receptors 1 and 2 on mouse splenic B cells using flow cytometry.
    Donius LR; Weis JH
    Methods Mol Biol; 2014; 1100():305-10. PubMed ID: 24218269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for an important interaction between a complement-derived CD21 ligand on follicular dendritic cells and CD21 on B cells in the initiation of IgG responses.
    Qin D; Wu J; Carroll MC; Burton GF; Szakal AK; Tew JG
    J Immunol; 1998 Nov; 161(9):4549-54. PubMed ID: 9794381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-linking CD21/CD35 or CD19 increases both B7-1 and B7-2 expression on murine splenic B cells.
    Kozono Y; Abe R; Kozono H; Kelly RG; Azuma T; Holers VM
    J Immunol; 1998 Feb; 160(4):1565-72. PubMed ID: 9469411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of a novel Cr2 gene allele by homologous recombination that abrogates production of Cr2 but is sufficient for expression of Cr1.
    Donius LR; Orlando CM; Weis JJ; Weis JH
    Immunobiology; 2014 Jan; 219(1):53-63. PubMed ID: 24012440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic CD21 deficiency is associated with hypogammaglobulinemia.
    Thiel J; Kimmig L; Salzer U; Grudzien M; Lebrecht D; Hagena T; Draeger R; Voelxen N; Bergbreiter A; Jennings S; Gutenberger S; Aichem A; Illges H; Hannan JP; Kienzler AK; Rizzi M; Eibel H; Peter HH; Warnatz K; Grimbacher B; Rump JA; Schlesier M
    J Allergy Clin Immunol; 2012 Mar; 129(3):801-810.e6. PubMed ID: 22035880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epitope mapping using the X-ray crystallographic structure of complement receptor type 2 (CR2)/CD21: identification of a highly inhibitory monoclonal antibody that directly recognizes the CR2-C3d interface.
    Guthridge JM; Young K; Gipson MG; Sarrias MR; Szakonyi G; Chen XS; Malaspina A; Donoghue E; James JA; Lambris JD; Moir SA; Perkins SJ; Holers VM
    J Immunol; 2001 Nov; 167(10):5758-66. PubMed ID: 11698449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of complement receptors 1 (CR1/CD35) and 2 (CR2/CD21), and co-signaling molecule CD19 in cattle.
    Pringle ES; Firth MA; Chattha KS; Hodgins DC; Shewen PE
    Dev Comp Immunol; 2012 Dec; 38(4):487-94. PubMed ID: 22989997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human complement receptor type 2 (CR2/CD21) transgenic mice provide an in vivo model to study immunoregulatory effects of receptor antagonists.
    Kulik L; Chen K; Huber BT; Holers VM
    Mol Immunol; 2011 Mar; 48(6-7):883-94. PubMed ID: 21269698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of the innate immune system to autoimmune diabetes: a role for the CR1/CR2 complement receptors.
    Noorchashm H; Moore DJ; Lieu YK; Noorchashm N; Schlachterman A; Song HK; Barker CF; Naji A
    Cell Immunol; 1999 Jul; 195(1):75-9. PubMed ID: 10433799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement-mediated activation of the adaptive immune responses: role of C3d in linking the innate and adaptive immunity.
    Toapanta FR; Ross TM
    Immunol Res; 2006; 36(1-3):197-210. PubMed ID: 17337780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a complement receptor 2 (CR2, CD21) ligand binding site for C3. An initial model of ligand interaction with two linked short consensus repeat modules.
    Molina H; Perkins SJ; Guthridge J; Gorka J; Kinoshita T; Holers VM
    J Immunol; 1995 May; 154(10):5426-35. PubMed ID: 7730644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anti-human CD21 antibody, BU33, identifies equine B cells.
    Mayall S; Siedek E; Hamblin AS
    J Comp Pathol; 2001 Jan; 124(1):83-7. PubMed ID: 11428193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement receptor type two (CR2,CR21): a target for influencing the humoral immune response and antigen-trapping.
    Prodinger WM
    Immunol Res; 1999; 20(3):187-94. PubMed ID: 10741859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of the Epstein Barr virus receptor found on Raji cells. II. A comparison of lymphocyte binding sites for Epstein Barr virus and C3d.
    Hutt-Fletcher LM; Fowler E; Lambris JD; Feighny RJ; Simmons JG; Ross GD
    J Immunol; 1983 Mar; 130(3):1309-12. PubMed ID: 6218205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel mechanism of alternative pathway complement activation accounts for the deposition of C3 fragments on CR2-expressing homologous cells.
    Schwendinger MG; Spruth M; Schoch J; Dierich MP; Prodinger WM
    J Immunol; 1997 Jun; 158(11):5455-63. PubMed ID: 9164968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation of residues in the C3dg region of human complement component C3 corresponding to a proposed binding site for complement receptor type 2 (CR2, CD21) does not abolish binding of iC3b or C3dg to CR2.
    Diefenbach RJ; Isenman DE
    J Immunol; 1995 Mar; 154(5):2303-20. PubMed ID: 7868901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell cycle control of a Burkitt lymphoma cell line: responsiveness to growth signals engaging the C3D/EBV receptor.
    Pernegger G; Schulz TF; Hosp M; Myones BL; Petzer AL; Eigentler A; Böck G; Wick G; Dierich MP
    Immunology; 1988 Oct; 65(2):237-41. PubMed ID: 2461345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of induced co-stimulation as a result of complement receptor 2 (CR2) ligation on mouse splenic B cells.
    Brown SL; Barrault DV; Phythian-Adams A; Knight AM
    Int Immunol; 2006 Jan; 18(1):69-78. PubMed ID: 16291653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody-independent B cell-intrinsic and -extrinsic roles for CD21/35.
    Rossbacher J; Haberman AM; Neschen S; Khalil A; Shlomchik MJ
    Eur J Immunol; 2006 Sep; 36(9):2384-93. PubMed ID: 16906534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.